E2 ModeratePreliminaryPEM ?Case-ControlPeer-reviewedMachine draft
Sex and disease severity-based analysis of steroid hormones in ME/CFS.
Pipper, Cornelia, Bliem, Linda, León, Luis E et al. · Journal of endocrinological investigation · 2024 · DOI
Quick Summary
Researchers measured hormone levels in the blood of ME/CFS patients and compared them to healthy people. They found that certain hormones—including cortisol-related compounds and progesterone—were different in people with ME/CFS, and the differences varied depending on whether patients had mild/moderate or severe disease and their sex. These hormone patterns might help doctors better identify and categorize ME/CFS in the future.
Why It Matters
Steroid hormone abnormalities may represent objective biomarkers for ME/CFS diagnosis and disease severity stratification, addressing a critical clinical need in a disease lacking definitive diagnostic tests. Sex-specific hormone patterns suggest that biological mechanisms and disease expression differ between males and females, which could inform more personalized treatment approaches and improve understanding of why ME/CFS disproportionately affects women.
Observed Findings
- Female patients with severe ME/CFS had significantly higher 11-deoxycortisol and 17α-hydroxyprogesterone compared to healthy controls and mild/moderate patients.
- Female patients with mild/moderate ME/CFS showed elevated progesterone levels versus healthy controls.
- Male patients with mild/moderate ME/CFS had lower cortisol and corticosterone but higher progesterone compared to healthy controls.
- Partial least squares discriminant analysis could distinguish ME/CFS from healthy controls with 71.2% accuracy in females and 84.6% accuracy in males.
- Multivariate analysis revealed differential hormone-association patterns between study groups beyond univariate findings.
Inferred Conclusions
- Steroid hormone profiles are significantly altered in ME/CFS and show sex-specific and severity-dependent patterns that may provide stratification value.
- Hormone dysregulation differs between males and females, suggesting sex-based biological heterogeneity in ME/CFS pathophysiology.
- Steroid hormone measurement warrants inclusion in future research aimed at improving ME/CFS diagnosis and patient classification.
- Sex-stratified analysis is essential for understanding ME/CFS biology and may enable personalized therapeutic approaches.
Remaining Questions
What This Study Does Not Prove
This study does not establish whether hormone abnormalities cause ME/CFS or result from it—the cross-sectional design prevents causal inference. It does not prove these hormones alone can reliably diagnose ME/CFS in clinical practice, as external validation in larger, independent populations is needed. The modest sample size, especially for males (n=6-8), limits generalizability of sex-specific findings.
Tags
Symptom:Post-Exertional MalaiseFatigue
Biomarker:Blood Biomarker
Phenotype:Severe
Method Flag:PEM Not DefinedSmall SampleSevere ME IncludedSex-Stratified